Scr/CysC Ratio
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Prognostic Value of Myosteatosis and Creatinine-to-cystatin C Ratio in Patients With Pancreatic Ductal Adenocarcinoma (NCT05584852) | The Affiliated Hospital of Qingdao University | 2022-11-01 |
Track Scr/CysC Ratio automatically
Every clearance here is in the API, with alerts when new ones post.